The size of the North American Sleep Apnea Devices Market was valued at USD 3.47 billion in 2021. This value is expected to grow at a CAGR of 8.1% to reach USD 5.12 billion by 2026.
Sleep apnea is a sleeping disorder that interrupts the breath by blocking the flow of the air. Sleep apnea devices use continuous positive airway pressure (CPAP), which helps the patient breathe easily.
The increasing number of people suffering from sleeping disorders, especially younger generations, leads to a constant demand for sleep apnea devices. The novel and advanced methods are continually flowing into the market due to the focused research and development activities, propelling the growth of the sleep apnea devices market in North America. The availability of advanced healthcare facilities, hospitals, and diagnostics centers in North America is also a significant factor that boosts the growth rate of the sleep apnea devices market in this region.
Patients feeling discomfort while using masks and high initial set up costs and maintenance costs of sleep apnea devices like CPAP, complications in therapies, are expected to limit the growth of the sleep apnea devices market in North America during the forecast period.
Unhealthy sleeping habits among many individuals and a rise in disposable income are anticipated to boost the market demand and provide lucrative growth opportunities for the key players in the market over the forecast period. R&D organizations and academic institutions focus on developing innovative products with advanced technology to enhance the efficiency of diagnosis, therapies, and devices such as smartphone assistance through the internet are boosting demand and improving the growth opportunities for the stakeholders and key players of the sleep apnea devices market in North America.
U.S. Sleep Apnea Devices Market:
The U.S. Sleep Apnea Devices Market is forecasted to be growing at a CAGR of 9.1% between 2020 to 2025 and was occupied the majority of the share in the North American market in 2019. In the US, approximately 22 million people are getting treatment for obstructive sleep apnea (OSA). Around 80% of them have moderate symptoms, whereas the rest are suffering from severe OSA cases. 85% of people are left undiagnosed in most of the countries in North America.
Adopting sedentary lifestyles and changes in food habits leads to various health disorders like obesity, diabetes, and others. Particularly in the US, more than 70 million adults are suffering from obesity problems. Ninety-nine million people are overweight. An increasing number of people suffering from sleep disorders is likely to boost the demand of the market. Around 30% of the adult population are diagnosed with insomnia, which is the most common sleep disorder. Growing awareness over the availability of different devices among people is leveraging the growth rate of the market. Also, the increasing prevalence of chronic diseases is boosting up the demand of the market. OSA is the most common disorder among older people where this is merely fuelling the demand of the market. The presence of international key players in this country is significantly influencing the growth rate of the market. The rising number of diagnostic procedures that evaluate to improve the proper treatment procedures for sleep disorders is lavishing the demand for sleep apnea devices in the United States.
This research report on the North America Sleep Apnea Devices Market has been segmented and sub-segmented into the following categories.
By Diagnostic Devices:
By Therapeutic Devices:
Regionally, North America captures around 40% of the global market share. North America is leading with the highest shares in the global sleep apnea devices market. Increasing investments in the development of innovative devices is a major factor for the market to grow in this region.
The USA sleep apnea devices market is currently dominating the North American market and is presumed to contribute the largest share of revenues to the market during the forecast period. The factors contributing to the growth of the sleep apnea devices market in North America are the increasing account of sleeping disorders and the obesity population, leading to rising demand for sleep apnea devices, technological advancements, and key market players.
The Canadian sleep apnea devices market contributes a significant share of revenues to the North American sleep apnea devices market. It is expected to maintain the trend due to inappropriate sleeping habits, increasing focus of key market players in R&D activities in this region to develop novel and innovative techniques and therapeutic procedures.
Prominent Companies leading the North America Sleep Apnea Devices Market are ResMed, Inc. (U.S.), Philips Healthcare (Netherlands), and Fisher & Paykel Healthcare Ltd. (New Zealand). Other players in the market include SomnoMed Ltd. (Australia), Compumedics Limited (Australia), Weinmann Medical Devices GmbH (Germany), Whole You, Inc. (U.S.).
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1.2 Sleep Apnea Therapeutic Devices Market
220.127.116.11 Positive Airway Pressure (PAP) Devices
18.104.22.168.1 CPAP Devices
22.214.171.124.2 APAP Devices
126.96.36.199.3 BPAP Devices
188.8.131.52 Facial Interfaces
184.108.40.206.1.1 Nasal Masks
220.127.116.11.1.2 Nasal Pillow Masks
18.104.22.168.1.3 Full-Face Masks
22.214.171.124 Adaptive Servo-Ventilation Instruments (ASV)
126.96.36.199 Airway Clearance Systems
188.8.131.52 Oxygen Concentrators
184.108.40.206.1 Stationary Concentrators
220.127.116.11.2 Portable Concentrators
18.104.22.168.2 Chin Restraints
22.214.171.124.3 Mask Cleaning Wipes
126.96.36.199.4 Other Accessories
188.8.131.52 Oral Appliances
184.108.40.206.1 Mandibular Advancement Devices
220.127.116.11.2 Tongue Retaining Devices
5.1.3 Sleep Apnea Diagnostic Devices Market
18.104.22.168 Polysomnography Devices
22.214.171.124.1 Ambulatory PSG Devices
126.96.36.199.2 Clinical PSG Devices
188.8.131.52 Respiratory Polygraphs
184.108.40.206 Single-Channel Screening Devices (Pulse Oximeters)
220.127.116.11.1 Fingertip Pulse Oximeters
18.104.22.168.2 Handheld Pulse Oximeters
22.214.171.124.3 Wrist-Worn Pulse Oximeters
126.96.36.199.4 Tabletop Pulse Oximeters
188.8.131.52 Actigraphy Systems
5.1.4 Y-o-Y Growth Analysis, By Product
5.1.5 Market Attractiveness Analysis, By Product
5.1.6 Market Share Analysis, By Product
5.2 End User
5.2.2 Home Care Setting
5.2.3 Sleep Laboratories and Hospitals
5.2.4 Y-o-Y Growth Analysis, By End User
5.2.5 Market Attractiveness Analysis, By End User
5.2.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End User
6.1.4 Market Attractiveness Analysis
22.214.171.124 By Geographical Area
126.96.36.199 By Product
188.8.131.52 By End User
6.1.5 Market Share Analysis
184.108.40.206 By Geographical Area
220.127.116.11 By Product
18.104.22.168 By End User
6.2 United States
7. Strategic Analysis
7.1 PESTLE analysis
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Resmed, Inc.
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Philips Healthcare
8.3 Fisher & Paykel Healthcare Ltd.
8.4 Somnomed Limited
8.5 Compumedics Limited
8.6 Weinmann Medical Devices GmbH
8.7 Whole You, Inc.
8.8 Devilbiss Healthcare LLC
8.9 BMC Medical Co., Ltd.
8.10 Braebon Medical Corporation
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
a) List of Tables
b) List of Figures